Drug Approval | August 08, 2023
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
The inspection closed with zero observations and a classification of No Action Indicated
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
The product is being launched in August 2023
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
Subscribe To Our Newsletter & Stay Updated
